2C-BFLY is a psychedelic phenethylamine and designer drug of the 2C family. It was first synthesized in 1996 by Aaron Monte, Professor of Chemistry at UW-La Crosse.
Kendall Newcomb Houk is a Distinguished Research Professor in Organic Chemistry at the University of California, Los Angeles. His research group studies organic, organometallic, and biological reactions using the tools of computational chemistry. This work involves quantum mechanical calculations, often with density functional theory, and molecular dynamics, either quantum dynamics for small systems or force fields such as AMBER, for solution and protein simulations.
Marion Frederick Hawthorne was an inorganic chemist who made contributions to the chemistry of boron hydrides, especially their clusters.
Dennis Liotta is a chemistry professor at Emory University in Atlanta, Georgia, United States. He is noted for his work on the development of antiviral drugs.
Gábor Béla Fodor was a Hungarian-American chemist, medical research scientist, and professor of chemistry. His work in academia, which spanned six decades in Europe and later in North America, specialized in research of antidotes, painkillers, tropane alkaloids, and derivatives of vitamin C. His research helped in finding treatments for cancer, strokes, Alzheimer's disease, and other illnesses.
The Journal of Labelled Compounds and Radiopharmaceuticals is a peer-reviewed scientific journal that was established in 1965. It is published in fourteen issues per year by John Wiley & Sons on behalf of the International Isotope Society and covers all aspects of research and development leading to and resulting in labelled compound preparation. The current editor-in-chiefs are R F Dannals and V Derdau.
Dale Lester Boger is an American medicinal and organic chemist and former chair of the Department of Chemistry at The Scripps Research Institute in La Jolla, CA.
Michael A. Marletta is an American biochemist. He was born in Rochester, New York, the son of Italian immigrants. He graduated from the State University of New York at Fredonia in 1973 with an A.B. degree in biology and chemistry, and from the University of California, San Francisco in 1978 with a Ph.D. degree in pharmaceutical chemistry, where he studied with George Kenyon. He was a postdoctoral fellow with Christopher T. Walsh at MIT from 1978-1980 and continued as a faculty member at MIT from 1980-1987 whereupon he joined the faculty of the University of Michigan, Ann Arbor. He was John G. Searle Professor of Medicinal Chemistry in the college of pharmacy and professor of biological chemistry at the University of Michigan. In 2001, he moved to the University of California, Berkeley to assume roles as Aldo DeBenedictis Distinguished Professor of Chemistry and professor of biochemistry and molecular biology, and served as the chair of the department of chemistry from 2005 until 2010. He was a Howard Hughes Medical Institute Investigator. From January 2012 to August 2014, Marletta was president and CEO of The Scripps Research Institute in La Jolla, California, succeeding Richard Lerner.
Philip Salvatore Portoghese is an American medicinal chemist who has made notable contributions to the design and synthesis of ligands targeting opioid receptors. He is a Distinguished Professor of Medicinal Chemistry at the University of Minnesota, Twin Cities. He also served as the Editor-in-chief of the Journal of Medicinal Chemistry from 1972 to 2012, when the job was taken on by his departmental colleague, Gunda I. Georg, who shares the Editor-in-chief position with Shaomeng Wang at the University of Michigan.
Current Medicinal Chemistry is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Atta-ur-Rahman, FRS. The journal covers developments in medicinal chemistry and rational drug design and publishes original research reports and review papers.
Mini-Reviews in Medicinal Chemistry is a monthly peer-reviewed medical journal covering all aspects of medicinal chemistry. It is published by Bentham Science Publishers and the editors-in-chief are Atta-ur-Rahman, M. Iqbal Choudhary, and George Perry.
The College of Science at the University of Utah is an academic college of the University of Utah in Salt Lake City, Utah. The college offers undergraduate and graduate degrees in atmospheric science, biology, chemistry, geology and geophysics, mathematics, metallurgical engineering, mining engineering and physics and astronomy.
Erick M. Carreira is a Cuban-born American organic chemist and professor at ETH Zürich. He is known for his research group's work in total synthesis projects, particularly asymmetric synthesis of complex natural products. He became the editor-in-chief of the Journal of the American Chemical Society in 2021.
Gunda I. Georg is a chemist who is currently the Professor and Head of the Department of Medicinal Chemistry, Regents Professor, McKnight Presidential Chair, Robert Vince Endowed Chair at University of Minnesota and a former Co-Editor-in-Chief of American Chemical Society's Journal of Medicinal Chemistry. Her research interests are total synthesis and semisynthesis as well as evaluating biologically active agents. A cited expert in her field, she was elected to the American Association for the Advancement of Science in 1996 and inducted in the Medicinal Chemistry Hall of Fame in 2017. In 2019, she was announced as the 2020 winner and first woman to receive the Alfred Burger Award in Medicinal Chemistry. She along with chemists, Shameem Syeda and Gustavo Blanco, are leading researchers in male contraception. Dr Georg also works with her research groups to conduct research on Alzheimer's disease, epilepsy and cancer experimental therapeutics.
Anti-Cancer Agents in Medicinal Chemistry is a peer-reviewed academic journal covering the disciplines of medicinal chemistry and drug design relating to chemotherapeutic agents in cancer. It is published by Bentham Science Publishers and the editor-in-chief is Simone Carradori. The journal covers developments in "medicinal chemistry and rational drug design for the discovery of anti-cancer agents" and publishes original research reports and review papers.
Jonathan Baell is trained as an Australian medicinal chemist and is currently executive director, early leads chemistry at Lyterian Therapeutics in San Francisco. Prior to this, he was a research professor in medicinal chemistry at the Monash Institute of Pharmaceutical Sciences (MIPS), the director of the Australian Translational Medicinal Chemistry Facility and a Chief Investigator at the ARC Centre for Fragment-Based Design. He was President of the International Chemical Biology Society 2018-2021 and is currently chair of the board. His research focuses on the early stages of drug discovery, including high-throughput screening (HTS) library design, hit-to-lead and lead optimization for the treatment of a variety of diseases, such as malaria and neglected diseases.
Alfred Burger was a prominent chemist and a pioneer in medical chemistry. Burger was born in Vienna, the capitol of the Austro-Hungarian Empire, on 6 September 1905. He was the son of S. L. Burger and Clariss Burger.
Walter Henry Hartung was an American pharmaceutical chemist. His work studied the chemical and biological properties of amines.
Amanda E. Hargrove is a chemist and professor at Duke University. Hargrove is also the editor-in-chief of Medicinal Research Reviews, and a member of the Scientific Advisory Board of Arrakis Therapeutics. At Duke University, Hargrove directs an interdisciplinary research program in chemical biology that focuses on harnessing the specific interactions between small molecules and RNA, and using those RNA-small molecule interactions to probe the structure, and function of RNA. The long-term goal of the group's research is to identify specific molecule-RNA interactions that may have therapeutic potential in the treatment of viral infection and human disease. She has received numerous awards for her scientific research, teaching, and service in support of diversity, equity, and inclusion.
Amy Hauck Newman is an American medicinal chemist who is the scientific director of the intramural research program at the National Institute on Drug Abuse. She researches the design, synthesis, and evaluation of central nervous system (CNS) active agents as potential treatment medications for substance use disorders, with an emphasis on selective ligands for the dopaminergic system.
